当前位置: 首页 > 期刊 > 《中国医学创新》 > 2012年第14期 > 正文
编号:12279946
心可舒胶囊配伍厄贝沙坦片治疗高血压左室肥厚心肌缺血的临床研究(3)
http://www.100md.com 2012年5月15日 张乃奇
第1页

    参见附件。

     [2] Wang S X, Xue H, Zou Y B, et al. Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese[J]. Chin Med J (Engl), 2012,125(1):21-26.

    [3] Sasongko L, Harahap Y, Prasaja B, et al. Comparative bioavailability of two irbesartan/hydrochlorothiazide tablet formulations in Indonesian healthy subjects[J].Arzneimittelforschung, 2010,60(12):749-753.

    [4] Zang Q, Zhou J Y, Sun N L. Effect of xinkeshu tablet on heart rate variability in patients with coronary heart disease [J].Zhongguo Zhong Xi Yi Jie He Za Zhi, 2008 ,28(5):402-405.

    [5] Tao X, Jing-Bo P, Wen-Tong Z, et al. Antiatherogenic and Anti-Ischemic Properties of Traditional Chinese Medicine Xinkeshu via Endothelial Protecting Function[J]. Evid Based Complement Alternat Med, 2012,302137(Epub 2011 Oct 10).

    [6] 陈建华.国内外的高血压诊断标准[J].中华实用中西医杂志,2010,23(4): 33-34.

    [7] 朱力华,方炳森.心电图诊断术语的规范化解读与应用[J].实用心电学杂志,2010,19(1):28-33.

    [8] Rosendorff C, Go O, Schmeidler J, et al.Correlation of arterial blood pressure and compliance with left ventricular structure and function in the very elderly[J]. J Am Soc Hypertens. 2012,6(1):48-55 ......

您现在查看是摘要介绍页,详见PDF附件(3818kb)